# TIC Solutions, Inc.: financial statements, quarterly

TIC · NYSE · CIK 2032966 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tic.md) · [Financials](/companies/tic/financials.md) · [Filings](/companies/tic/filings.md) · [Insiders](/companies/tic/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tic/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-06-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [309](/filings/0002032966-25-000027.md) | [234](/filings/0001628280-26-030885.md) | [314](/filings/0001628280-26-053831.md) | [474](/filings/0001628280-25-051303.md) | [508 d](/filings/0001628280-26-017015.md) | [488](/filings/0001628280-26-030885.md) | [584](/filings/0001628280-26-053831.md) |
| Cost of revenue | $m | [229](/filings/0002032966-25-000027.md) | [191](/filings/0001628280-26-030885.md) | [240](/filings/0001628280-26-053831.md) | [321](/filings/0001628280-25-051303.md) | [329 d](/filings/0001628280-26-017015.md) | [327](/filings/0001628280-26-030885.md) | [380](/filings/0001628280-26-053831.md) |
| Gross profit | $m | [80.6](/filings/0002032966-25-000027.md) | [43.7](/filings/0001628280-26-030885.md) | [74.1](/filings/0001628280-26-053831.md) | [153](/filings/0001628280-25-051303.md) | [179 d](/filings/0001628280-26-017015.md) | [161](/filings/0001628280-26-030885.md) | [204](/filings/0001628280-26-053831.md) |
| Selling, general and administrative | $m | [60.9](/filings/0002032966-25-000027.md) | [39.9](/filings/0001628280-26-030885.md) | [55.8](/filings/0001628280-26-053831.md) | [140](/filings/0001628280-25-051303.md) | [193 d](/filings/0001628280-26-017015.md) | [150](/filings/0001628280-26-030885.md) | [193](/filings/0001628280-26-053831.md) |
| Operating income | $m | [19.7](/filings/0002032966-25-000027.md) | [(9.4)](/filings/0001628280-26-030885.md) | [18.4](/filings/0001628280-26-053831.md) | [(6.5)](/filings/0001628280-25-051303.md) | [(19.5) d](/filings/0001628280-26-017015.md) | [(29.1)](/filings/0001628280-26-030885.md) | [10.8](/filings/0001628280-26-053831.md) |
| Income tax | $m | [7.9](/filings/0002032966-25-000027.md) | [1.5](/filings/0001628280-26-030885.md) | [3.9](/filings/0001628280-26-053831.md) | [(16.6)](/filings/0001628280-25-051303.md) | [0.1 d](/filings/0001628280-26-017015.md) | [(16.5)](/filings/0001628280-26-030885.md) | [(3.2)](/filings/0001628280-26-053831.md) |
| Net income | $m | [(5.5)](/filings/0002032966-25-000027.md) | [(25.8)](/filings/0001628280-26-053831.md) | [(0.2)](/filings/0001628280-26-053831.md) | [(13.9)](/filings/0001628280-25-051303.md) | [(47.2) d](/filings/0001628280-26-017015.md) | [(41.5)](/filings/0001628280-26-053831.md) | [(13.3)](/filings/0001628280-26-053831.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | [(0.08)](/filings/0001628280-25-051303.md) | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted

## Balance sheet

| Line item | Unit | period not labelled (2024-07-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | [139](/filings/0001628280-26-017015.md) | [156](/filings/0002032966-25-000018.md) | [130](/filings/0002032966-25-000027.md) | [164](/filings/0001628280-25-051303.md) | [440](/filings/0001628280-26-053831.md) | [427](/filings/0001628280-26-030885.md) | [362](/filings/0001628280-26-053831.md) |
| Current assets | $m | not reported | not reported | [394](/filings/0001628280-26-017015.md) | [377](/filings/0002032966-25-000018.md) | [399](/filings/0002032966-25-000027.md) | [792](/filings/0001628280-25-051303.md) | [1,021](/filings/0001628280-26-053831.md) | [1,020](/filings/0001628280-26-030885.md) | [1,014](/filings/0001628280-26-053831.md) |
| Total assets | $m | not reported | [2,328](/filings/0001628280-25-051303.md) | [2,208](/filings/0001628280-26-017015.md) | [2,180](/filings/0001628280-26-030885.md) | [2,242](/filings/0001628280-26-053831.md) | [4,220](/filings/0001628280-25-051303.md) | [4,396](/filings/0001628280-26-053831.md) | [4,332](/filings/0001628280-26-030885.md) | [4,293](/filings/0001628280-26-053831.md) |
| Current liabilities | $m | not reported | not reported | [106](/filings/0001628280-26-017015.md) | [108](/filings/0002032966-25-000018.md) | [119](/filings/0002032966-25-000027.md) | [329](/filings/0001628280-25-051303.md) | [319](/filings/0001628280-26-053831.md) | [333](/filings/0001628280-26-030885.md) | [348](/filings/0001628280-26-053831.md) |
| Total liabilities | $m | not reported | not reported | [1,057](/filings/0001628280-26-017015.md) | [1,051](/filings/0002032966-25-000018.md) | [1,063](/filings/0002032966-25-000027.md) | [2,270](/filings/0001628280-25-051303.md) | [2,216](/filings/0001628280-26-053831.md) | [2,198](/filings/0001628280-26-030885.md) | [2,196](/filings/0001628280-26-053831.md) |
| Long-term debt | $m | not reported | not reported | [747](/filings/0001628280-26-017015.md) | [745](/filings/0002032966-25-000018.md) | [744](/filings/0002032966-25-000027.md) | [1,591](/filings/0001628280-25-051303.md) | [1,588](/filings/0001628280-26-053831.md) | [1,585](/filings/0001628280-26-030885.md) | [1,590](/filings/0001628280-26-053831.md) |
| Current portion of debt | $m | not reported | not reported | [7.8](/filings/0001628280-26-017015.md) | [7.7](/filings/0002032966-25-000018.md) | [7.7](/filings/0002032966-25-000027.md) | [24.5](/filings/0001628280-25-051303.md) | [25.5](/filings/0001628280-26-053831.md) | [23.5](/filings/0001628280-26-030885.md) | [23.1](/filings/0001628280-26-053831.md) |
| Shareholders' equity | $m | [556](/filings/0001628280-26-017015.md) | [1,211](/filings/0001628280-25-051303.md) | [1,151](/filings/0001628280-26-053831.md) | [1,129](/filings/0001628280-26-053831.md) | [1,179](/filings/0001628280-26-053831.md) | [1,951](/filings/0001628280-25-051303.md) | [2,180](/filings/0001628280-26-053831.md) | [2,134](/filings/0001628280-26-053831.md) | [2,096](/filings/0001628280-26-053831.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [32.8](/filings/0001628280-26-030885.md) | [(6.5) d](/filings/0001628280-26-053831.md) | [19.0 d](/filings/0001628280-25-051303.md) | [49.7 d](/filings/0001628280-26-017015.md) | [9.9](/filings/0001628280-26-030885.md) | [(9.8) d](/filings/0001628280-26-053831.md) |
| Capital expenditure | $m | [4.5](/filings/0001628280-26-030885.md) | [8.0 d](/filings/0001628280-26-053831.md) | [8.7 d](/filings/0001628280-25-051303.md) | [12.6 d](/filings/0001628280-26-017015.md) | [5.7](/filings/0001628280-26-030885.md) | [19.7 d](/filings/0001628280-26-053831.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Shares outstanding: 218,220,356 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-053831.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.